RaySearch Laboratories AB (publ) (STO: RAY.B)

Market Cap	5.39B
Revenue (ttm)	1.13B
Net Income (ttm)	151.22M
Shares Out	34.28M
EPS (ttm)	4.41
PE Ratio	35.64
Forward PE	38.91
Dividend	0.70 (0.45%)
Ex-Dividend Date	May 23, 2024

Volume	30,497
Open	154.40
Previous Close	154.60
Day's Range	153.00 - 158.00
52-Week Range	77.40 - 163.60
Beta	1.26
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment ...

• Industry: Health Information Services
• Sector: Healthcare
• CEO: Johan Lof
• Employees: 389
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: RAY.B

Financial Performance

In 2023, RAY.B's revenue was 1.02 billion, an increase of 21.16% compared to the previous year's 843.65 million. Earnings were 81.57 million, an increase of 243.06%.